Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension

Recent studies have linked proton pump inhibitor (PPI) treatment to increased complications of cirrhosis, such as bacterial infections and hepatic encephalopathy. However, the underlying pathophysiological mechanisms remain unclear. The present study investigated the hypothesis that PPI treatment ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturm, Lukas, Hirose, Misa, Stolz, Laura, Schultheiss, Michael, Zoldan, Katharina, Reincke, Marlene, Huber, Jan Patrick, Kaeser, Rafael, Boettler, Tobias, Thimme, Robert, Albert, Elisabeth, Busch, Hauke, Künstner, Axel, Bettinger, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653923/
https://www.ncbi.nlm.nih.gov/pubmed/37623323
http://dx.doi.org/10.1128/mbio.00492-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653923/
https://www.ncbi.nlm.nih.gov/pubmed/37623323
http://dx.doi.org/10.1128/mbio.00492-23

Ejemplares similares